Moderacja
Moderacja komentarza
Rodney: I'm from England how write an essay Goldman Sachs analysts raised the price target on thecompany's stock to $329 from $298, saying that investors areunderappreciating the long-term growth potential of company'seye drug Eylea, particularly for the treatment of vision lossdue to diabetes.